Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: A prospective clinical study

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 6, 2007, Pages 565-570

  Lorenz, Reinhard ^a   Kienast, Joachim ^b   Otto, Ulrich ^c   Kiehl, Michael ^b   Schreiter, Dierk ^c   Haertel, Sabine ^d   Barthels, Monika ^e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d CSL BEHRING GMBH   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Anticoagulation reversal; Blood coagulation factors; Emergencies; Hemorrhage; Oral anticoagulants; Phenprocoumon; Prothrombin complex concentrates; Surgery

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; COUMARIN DERIVATIVE; PHENPROCOUMON; PROTEIN C; PROTHROMBIN; PROTHROMBIN COMPLEX;

AGED; ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; CLINICAL EFFECTIVENESS; CLINICAL STUDY; CONFIDENCE INTERVAL; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; EMERGENCY; EVALUATION; FEMALE; HUMAN; INFUSION RATE; INTERNATIONAL NORMALIZED RATIO; INVASIVE PROCEDURE; MALE; MULTIPLE CYCLE TREATMENT; NANOFILTER; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; FEMALE; HEMORRHAGE; HEMOSTASIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PHENPROCOUMON; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE;

EID: 34548355019     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3282010d7a     Document Type: Article

References (36)

1. Hanley JP. Warfarin reversal. J Clin Pathol 2004; 57:1132-1139.
2. Makris M, Watson HG. The management of coumarin-induced over-anticoagulation. Br J Haematol 2001; 114:271-280.
3. Franke CL, de Jonge J, van Swieten JC, Op de Coul AA, van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke 1990; 21:726-730.
4. Butler AC, Tait RC. Management of oral anticoagulant-induced intracranial haemorrhage. Blood Rev 1998; 12:35-44.
5. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003; 107:1692-1711.
6. van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 1993; 153:1557-1562.
7. Schulman S. Care of patients receiving long-term anticoagulant therapy. N Engl J Med 2003; 349:675-683.
8. Haemostasis and Thrombosis Task Force for the British Committee for Standards in Haematology. Guidelines on oral anticoagulation: third edition. Br J Haematol 1998; 101:374-387.
9. Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Managing oral anticoagulant therapy. Chest 2001; 119:22S-38S.
10. Executive Committee and Scientific Advisory Committee of the Federal Physicians Chamber. Prothrombin complex concentrate. Guidelines for Therapy with Blood Components and Plasma Derivatives. 2nd ed. Köln: Deutscher Ärzte-Verlag GmbH; 2002. pp. 95-111.
11. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004; 181:492-497.
12. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126:11-28.
13. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992; 23:972-977.
14. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77:477-480.
15. Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 1999; 45:1113-1118.
16. Cartmill M, Dolan G, Byrne JL, Byrne PO. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 2000; 14:458-461.
17. Yasaka M, Sakata T, Naritomi H, Minematsu K. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res 2005; 115:455-459.
18. Makris M. Optimisation of the prothrombin complex concentrate dose for warfarin reversal. Thromb Res 2005; 115:451-453.
19. Römisch J, Gröner A, Bernhardt D, Diehl KH, Hein B, List W, et al. Nanofiltration bei der Herstellung von Beriplex® P/N: Erhöhung der Kapazität zur Viruseliminierung unter Beibehaltung der Produktqualität. Beitr Infusionsther Transfusionsmed 1996; 33:220-224.
20. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 2006; 4:967-970.
21. Römisch J, Bonik K, Müller H-G. Comparative in vitro investigation of prothrombin complex concentrates. Semin Thromb Hemost 1998; 24:175-181.
22. Evans G, Luddington R, Baglin T. Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol 2001; 115:998-1001.
23. Preston FE, Laidlaw ST, Sampson B, Kitchen S. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 2002; 116:619-624.
24. Stephens EA, Lee D, Brown S, Parapia L. The use of a prothrombin complex (Beriplex) to reverse oral anticoagulation and other clotting abnormalities - a three year audit. Presented at the European Hematology Association 7th Annual Congress; 7-9 June 2002; Florence, Italy.
25. Sharples R, Burnett C, Murphy M, Hanley JP. Prospective evaluation of a regional protocol for a rapid warfarin reversal in major haemorrhage. Br J Haematol 2003; 121 (Suppl 1):3-4.
26. Sharples R. The safety and efficacy of Beriplex P/N for rapid warfarin reversal in major hemorrhage - a prospective evaluation of a regional protocol [abstract]. J Thromb Haemost 2003; 1 (Suppl 1):P1115.
27. Gadisseur AP, van der Meer FJ, Adriaansen HJ, Fihn SD, Rosendaal FR. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon. Br J Haematol 2002; 117:940-946.
28. Fihn SD, Gadisseur AA, Pasterkamp E, van der Meer FJ, Breukink-Engbers WG, Geven-Boere LM, et al. Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon. Thromb Haemost 2003; 90:260-266.
29. Haustein KO. Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon. Semin Thromb Hemost 1999; 25:5-11.
30. Paul B, Oxley A, Brigham K, Cox T, Hamilton PJ. Factor II, VII, IX and X concentrations in patients receiving long term warfarin. J Clin Pathol 1987; 40:94-98.
31. Kumar S, Haigh JR, Tate G, Boothby M, Joanes DN, Davies JA, et al. Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance. Br J Haematol 1990; 74:82-85.
32. Staudinger T, Frass M, Rintelen C, Quehenberger P, Wagner O, Stoiser B, et al. Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients. Intensive Care Med 1999; 25:1105-1110.
33. Lorenz R, Kienast J, Otto U, Egger K, Kiehl M, Schreiter D, et al. Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol 2003; 15:15-20.
34. Lubetsky A, Hoffman R, Zimlichman R, Eldor A, Zvi J, Kostenko V, et al. Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation. Thromb Res 2004; 113:371-378.
35. Rodewald L, Scharrer I. Protein chemical investigation of 30 consecutive lots of double-virus eliminated PCC (Beriplex P/N) and summary of safety data [abstract]. Hämostaseologie 2004; 24:A46.
36. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke 2006; 37:256-262.